In Q4FY17 the consolidated sales / income from operations was at Rs 6,825 crores
The tablets will be manufactured at its Goa facility Glenmark Pharmaceuticals has been granted final approval by the US FDA for Olmesartan Medoxomil tablets, 5...
The event was attended by delegates from the industry who offered their insights on the theme ‘Reshaping the future of Pharma’
Cipla reports Q4 net loss of Rs. 61.8 crores, whereas the revenue was up by 8 per cent
The addition serves to establish Havas Health & You with a cornerstone health-and-wellness agency in the growing Indian market
The global growth hormone deficiency (GHD) space, which covers the seven major markets is set to rise to $2.08 billion by 2026
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas
Net Sales for the 12 months ended March 2017 grew by 7.9 per cent, the Board recommends a final dividend of Rs 25/- per share
Tildrakizumab is being evaluated for treatment of moderate-to-severe plaque psoriasis
During FY 2016-2017 total income stood at ₹ 726.4 crore in comparison to ₹ 770.8 crore recorded in the previous corresponding period. Board recommends dividend...
It is a monoclonal antibody developed for the treatment of solid tumours soft tissue sarcomas GNH India, pharmaceutical wholesaler, has imported a life-saving medicine called...
Enriched with 11 organic herbal actives, ITIS Plus Care Eye Drops brings relief to tired and irritated eyes
High Court of Delhi grants permanent injunction against the manufacture and sale of Sinopharm's amoxicillin active pharmaceutical ingredient in India
Documentary evidence of communication may protect manufacturers from the claim of overcharging the medicine
The initiative has been rolled out in five states and by next month, it will be introduced in 17 more states Children suffering from tuberculosis...
By Swati Rana-Mumbai Further clarifications are needed before it comes into force The much awaited Goods and Services Tax (GST) which will be applicable from...
Boehringer Ingelheim, a global pharma major, recently announced its plans to strategically realign its business focus areas. Sharad Tyagi, MD, Boehringer Ingelheim India, divulges more details about India’s role...
According to GN Singh, Drug Controller General (India) a set of new procedures to facilitate clinical trials are expected to be unveiled shortly
The proposal is to increase the production capacity of 66 APIs and API intermediates
The board of directors recommended a dividend at the rate of Rs 30 per equity share of Rs 10 each
The drug is indicated for the treatment of schizophrenia
Presents 6th Dr Malati Allen Noble Award to some of the toppers of 196 homoeopathic medical colleges of the country
FlexFactory will make DRL biopharmaceutical manufacturing set-up more flexible and efficient
The company achieved 95 per cent of the guidance with H2 FY 17 EBITDA at Rs 4,200 million despite a challenging operating environmen
A study funded by amfAR, The Foundation for AIDS Research, suggests that vaccines might play a role in curing the disease
The new method will rapidly deploy newly discovered bacterial CRISPR systems in disease-specific applications
The primary objective of the programme is to forge an industry-academia collaborative mission for accelerating discovery research to early development for biopharmaceuticals